MCID: LYM019
MIFTS: 55

Lymphosarcoma

Categories: Rare diseases, Cancer diseases, Immune diseases

Aliases & Classifications for Lymphosarcoma

Summaries for Lymphosarcoma

MalaCards based summary : Lymphosarcoma, also known as malignant lymphoma, is related to testicular lymphoma and reticulosarcoma. An important gene associated with Lymphosarcoma is MIR19A (MicroRNA 19a
six mature miRNAs (miR-17-5p, miR-17-3p, miR-19a, miR-19b, miR-20 and miR-92-1) in the cell lines with a 13q31 gain/amplification displays overexpression significantly higher than in those without.), and among its related pathways/superpathways are Chromatin Regulation / Acetylation and B cell receptor signaling pathway (KEGG). The drugs Teniposide and rituximab have been mentioned in the context of this disorder. Affiliated tissues include b cells, t cells and bone, and related phenotype is Reduced mammosphere formation.

Wikipedia : 76 Lymphoma is a group of blood cancers that develop from lymphocytes (a type of white blood cell). The... more...

Related Diseases for Lymphosarcoma

Diseases related to Lymphosarcoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 113)
# Related Disease Score Top Affiliating Genes
1 testicular lymphoma 32.0 BCL6 PTPRC
2 reticulosarcoma 29.5 BCL6 PTPRC
3 mediastinal malignant lymphoma 12.0
4 burkitt lymphoma 11.5
5 lymphoproliferative syndrome, x-linked, 1 11.4
6 mantle cell lymphoma 11.3
7 breast lymphoma 11.2
8 lymphoproliferative syndrome 2 11.0
9 diffuse large b-cell lymphoma 10.9
10 lymphoma, small cleaved-cell, diffuse 10.9
11 meningococcal infection 10.5 G6PD GSR
12 glucosephosphate dehydrogenase deficiency 10.5 G6PD H6PD
13 leukemia 10.4
14 testis seminoma 10.4 DNMT3A PTPRC
15 heart lymphoma 10.4 BCL6 PTPRC
16 nodular lymphocyte predominant hodgkin lymphoma 10.3 BCL6 PTPRC
17 senile cataract 10.3 G6PD GSR
18 epidural neoplasm 10.3 BCL6 PTPRC
19 plasmablastic lymphoma 10.2 BCL6 PTPRC
20 bone lymphoma 10.2 BCL6 CD22
21 lymphatic system cancer 10.2 BCL6 PTPRC
22 small intestine lymphoma 10.1 CD22 CTSL PTPRC
23 lymphoma 10.1
24 leukemia, acute lymphoblastic 3 10.1
25 lung lymphoma 10.0 BCL6 CD22
26 colon lymphoma 10.0 BCL6 CD22 PTPRC
27 hepatitis 9.9
28 mediastinitis 9.9
29 mature b-cell neoplasm 9.9 BCL6 PTPRC
30 acute leukemia 9.8
31 inflammatory bowel disease 9.8
32 hypersplenism 9.8
33 myeloid leukemia 9.8
34 neuropathy 9.8
35 lymphoid leukemia 9.7
36 thrombosis 9.7
37 sarcoma 9.7
38 hemopericardium 9.7
39 pericardial effusion 9.7
40 uveitis 9.7
41 plasmacytoma 9.7
42 histiocytoma 9.7
43 pneumonia 9.7
44 hodgkin's granuloma 9.7
45 paraneoplastic syndromes 9.7
46 lymphoma, hodgkin, classic 9.6 BCL6 MIR20A PTPRC
47 hematologic cancer 9.6 BCL6 CD22 NR3C1 PTPRC
48 complement component 4, partial deficiency of 9.6
49 holt-oram syndrome 9.6
50 ascites, chylous 9.6

Graphical network of the top 20 diseases related to Lymphosarcoma:



Diseases related to Lymphosarcoma

Symptoms & Phenotypes for Lymphosarcoma

GenomeRNAi Phenotypes related to Lymphosarcoma according to GeneCards Suite gene sharing:

26
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Reduced mammosphere formation GR00396-S 9.1 BCL6 CD22 CTSL DNMT3A NR3C1 PTPRC

Drugs & Therapeutics for Lymphosarcoma

Drugs for Lymphosarcoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 962)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Teniposide Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 29767-20-2 34698
2
rituximab Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 174722-31-7 10201696
3
Gemcitabine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable 95058-81-4 60750
4
Vidarabine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 24356-66-9 32326 21704
5
Lenograstim Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 135968-09-1
6
Fludarabine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 21679-14-1, 75607-67-9 30751
7
Etoposide Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 33419-42-0 36462
8
Menthol Approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable,Early Phase 1 2216-51-5 16666
9
Cisplatin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 15663-27-1 84093 441203 2767
10
Doxorubicin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 23214-92-8 31703
11
Dasatinib Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 302962-49-8 3062316
12
Hydrocortisone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 50-23-7 5754
13
Dacarbazine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 4342-03-4 5351166
14
Denileukin diftitox Approved, Investigational Phase 4,Phase 2,Phase 1,Not Applicable 173146-27-5
15
Vinblastine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 865-21-4 13342 241903
16
Mechlorethamine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 51-75-2 4033
17
Ifosfamide Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 3778-73-2 3690
18
Tropisetron Approved, Investigational Phase 4,Not Applicable 105826-92-4, 89565-68-4 5595
19
Iron Approved Phase 4,Phase 3,Phase 1,Phase 2,Early Phase 1,Not Applicable 7439-89-6 23925
20
Aprepitant Approved, Investigational Phase 4,Phase 2,Phase 1,Not Applicable,Early Phase 1 170729-80-3 151165 6918365
21
Dopamine Approved Phase 4,Phase 3,Phase 2,Not Applicable 51-61-6, 62-31-7 681
22
Clarithromycin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 81103-11-9 84029
23
Mesna Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 3375-50-6 598
24
Vincristine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 2068-78-2, 57-22-7 5978
25
Methotrexate Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 1959-05-2, 59-05-2 126941
26
Cytarabine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 147-94-4 6253
27
Zidovudine Approved Phase 4,Phase 2,Not Applicable 30516-87-1 35370
28
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 22916-47-8 4189
29
Thiotepa Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 52-24-4 5453
30
Cyclophosphamide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 50-18-0, 6055-19-2 2907
31
Metronidazole Approved Phase 4,Phase 3,Phase 2 443-48-1 4173
32
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 50-02-2 5743
33
Valproic Acid Approved, Investigational Phase 4,Phase 2,Phase 1,Early Phase 1 99-66-1 3121
34
Busulfan Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 55-98-1 2478
35
Idarubicin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 58957-92-9 42890
36
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 50-24-8 5755
37
Oxaliplatin Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 61825-94-3 5310940 9887054 43805 6857599
38
Palonosetron Approved, Investigational Phase 4,Phase 2,Not Applicable 135729-61-2, 119904-90-4, 135729-56-5 148211
39
Everolimus Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable 159351-69-6 6442177
40
Amoxicillin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 26787-78-0 33613
41
Tacrolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 104987-11-3 445643 439492
42
Melphalan Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 148-82-3 4053 460612
43
Mycophenolic acid Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 24280-93-1 446541
44
Mitoxantrone Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 65271-80-9 4212
45
Bexarotene Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 153559-49-0 82146
46
Daunorubicin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 20830-81-3 30323
47
Benzocaine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 1994-09-7, 94-09-7 2337
48
Amifostine Approved, Investigational Phase 4,Phase 2,Phase 1 20537-88-6 2141
49
Mycophenolate mofetil Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 128794-94-5 5281078
50
Granisetron Approved, Investigational Phase 4,Phase 2,Not Applicable 109889-09-0 3510

Interventional clinical trials:

(show top 50) (show all 6499)
# Name Status NCT ID Phase Drugs
1 Intensification Therapy of Mature B-ALL, Burkitt and Burkitt Like and Other High Grade Non-Hodgkin's Lymphoma in Adults Unknown status NCT00797810 Phase 4 Rituximab
2 Low Grade Lymphoma Unknown status NCT01698866 Phase 4
3 CEOP/IVE/GDP Compared With CEOP as the First-line Therapy for Newly Diagnosed Adult Patients With PTCL Unknown status NCT02533700 Phase 4 CEOP/IVE/GDP chemotherapy regimen;CEOP chemotherapy regimen for 6 cycles
4 Optimization of the Primary Therapy for Patients With Hodgkin's Disease and Evaluation of PET Unknown status NCT00188149 Phase 4 Combined chemotherapy (ABVD, BACOPP-D)
5 Self-control Trial to Evaluate the Role of Aprepitant in the Prophylaxis of Post-lumbar-punture-headache (PLPH) Unknown status NCT02347878 Phase 4 Aprepitant
6 Study Comparing Sequential and Concomitant Therapy for Helicobacter Pylori Eradication in Routine Clinical Practice Unknown status NCT01273441 Phase 4 PPI, amoxicillin, metronidazole and clarithromycin;PPI, amoxicillin, metronidazole and clarithromycin
7 Low-dose Chemotherapy Combine With Tyrosine Kinase Inhibitor to Treat ph+ Acute Lymphoblastic Leukemia Patients Unknown status NCT02690922 Phase 4 Dasatinib;prednisone;dexamethasone;methotrexate
8 HD-Idarubicin/Etoposide Intensified Conditioning Regimen Allo-HSCT for Adult ALL Unknown status NCT01873807 Phase 4 IDA;CTX;VP-16
9 Medical Research Council (MRC) Working Party on Leukaemia in Children UK National Acute Lymphoblastic Leukaemia (ALL) Trial: UKALL 2003 Unknown status NCT00222612 Phase 4 Standard childhood UK ALL protocol;Intensified treatment including Capizzi maintenance
10 Poly(Ethylene Glycol)(PEG)-Asparaginase During Two Treatment Courses Unknown status NCT00192673 Phase 4 PEG-asparaginase
11 German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003) Unknown status NCT00198991 Phase 4 Cyclophosphamide;Dexamethasone;Vincristine;daunorubicin;Asparaginase;Methotrexate;Cytarabine;Mercaptopurine;G-CSF;Vindesine;VP16;Prednisolone;Adriamycin;Thioguanine;VM26;Idarubicin;Fludarabine;Cladribine
12 German Multicenter Trial for Treatment of Elderly Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Unknown status NCT00198978 Phase 4 Cyclophosphamide;Dexamethasone / Prednisolone;Cytarabine;Idarubicin;Granulocyte-Colony-Stimulating Factor;Mercaptopurine;Methotrexate;Rituximab;HDARAC;Vincristine;Depocyte;Asparaginase
13 Treatment Protocol of Children With Philadelphia Chromosome Negative High Risk Acute Lymphoblastic Leukemia Unknown status NCT01990807 Phase 4 Idarubicin(IDA)
14 Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer Unknown status NCT00274885 Phase 4 oxaliplatin
15 Zevalin® Followed by Rituxan® Maintenance in Previously Treated Low Grade Non-Hodgkin’s Lymphoma Completed NCT00168727 Phase 4 ibritumomab tiuxetan (Zevalin®)
16 An Open Label Treatment Use Protocol for Ibrutinib in Subjects With Relapsed or Refractory Mantle Cell Lymphoma Completed NCT01833039 Phase 4 Ibrutinib
17 Treatment of Peripheral T-cell Lymphoma Completed NCT01664975 Phase 4 GDPT regimen;CHOP regimen
18 PEG-rhG-CSF in Patients With Lymphoma Receiving Chemotherapy Completed NCT02805218 Phase 4 PEG-rhG-CSF
19 MAXIMA Study: A Study of Maintenance Therapy With MabThera (Rituximab) in Patients With Non-Hodgkin's Lymphoma. Completed NCT00430352 Phase 4 rituximab [MabThera/Rituxan]
20 Study of ONTAK® to Treat Cutaneous T-Cell Lymphoma (CTCL) Completed NCT00211198 Phase 4 ONTAK (denileukin difitox, DAB389IL-2)
21 Study Evaluating Two Dose Levels of Targretin Capsules in Patients With Refractory Cutaneous T-cell Lymphoma (CTCL) Completed NCT01007448 Phase 4 bexarotene;bexarotene
22 Doxorubicin Pharmacokinetics and Response in Non Hodgkin's Lymphoma Completed NCT00969462 Phase 4 Doxorubicin
23 Evaluation of Approved Weight-Based Dose Compared to Fixed Dose of Plerixafor in Patients With Non-Hodgkin's Lymphoma (NHL) Weighing Less Than 70 Kilograms Completed NCT01164475 Phase 4 Granulocyte-colony stimulating factor (G-CSF);Fixed Dose Plerixafor;Weight-Based Plerixafor
24 German Multicenter Trial for the Treatment of Newly Diagnosed T-lymphoblastic Lymphoma in Adults Completed NCT00199017 Phase 4 Dexamethasone/Prednisolone;Cyclophosphamide;Vincristine;Daunorubicin;Asparaginase;G-CSF;Mercaptopurine;Cytarabine;Methotrexate;VP16;Vindesine;Adriamycin;Thioguanine;HDARAC;Cladribine
25 Efficacy Response Duration and Toxicity of Rituximab, Fludarabine, and Cyclophosphamide (RFC) as 1st Line Treatment and Rituximab (R) in Maintenance Treatment in Follicular Non Hodgkin (FNH) Lymphoma Completed NCT01124526 Phase 4 Rituximab Fludarabine Cyclophosphamide
26 Whole Brain Irradiation in Primary Central Nervous System (CNS) Lymphoma (PCNSL) Completed NCT00153530 Phase 4 methotrexate
27 Prophylactic Use of Entecavir for Non-Hodgkin's Lymphoma Patients With Resolved Hepatitis B Completed NCT00926757 Phase 4 Entecavir prophylaxis;Therapeutic entecavir
28 Carbohydrate Metabolism Disorder Frequency in Hypertriglyceridemia Induced by Bexarotene of Cutaneous T Cell Lymphoma Completed NCT01569724 Phase 4
29 An Expanded Access Program of Pegfilgrastim (Neulastim) in Participants With Non-Hodgkin's Lymphoma (NHL) Completed NCT02782845 Phase 4 Chemotherapy;Immunochemotherapy;Pegfilgrastim
30 LINFOTARGAM: Treatment With Chemotherapy Plus Rituximab and Highly Active Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus (HIV) Completed NCT00466258 Phase 4 R-CHOP;Highly active antiretroviral therapy;Central nervous system (CNS) prophylaxis;Prophylaxis of opportunistic infections and support treatment
31 Study of ONTAK (Denileukin Diftitox) in Cutaneous T-Cell Lymphoma (CTCL) Patients Completed NCT00050999 Phase 4 ONTAK
32 Study of ONTAK (Denileukin Diftitox) in Previously Treated Cutaneous T-Cell Lymphoma Patients Completed NCT00051012 Phase 4 ONTAK
33 Effect of Rituximab on Immunological Recall Response to Specific Antigens in the Treatment of Non-Hodgkin's Lymphoma Completed NCT00090038 Phase 4 rituximab
34 Study of Rasburicase as Treatment or Prevention of Hyperuricemia Associated With Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumor Malignancy Completed NCT00230217 Phase 4 Rasburicase (SR29142)
35 Trial for the Treatment of Newly Diagnosed Mature B-Cell Acute Lymphoblastic Leukemia (B-ALL), Burkitt's Non-Hodgkin's Lymphoma (NHL) and Other High-grade Lymphoma in Adults Completed NCT00199082 Phase 4 Adriamycin;Cyclophosphamide;Cytarabine;Dexamethasone/Prednisolone;VP16;Ifosfamide;Methotrexate;G-CSF;Rituximab;Vincristine/Vindesine
36 Prevention of CHOP-induced Chronic Cardiotoxicity Completed NCT00162955 Phase 4 Valsartan
37 Photopheresis as an Interventional Therapy for the Treatment of CTCL (Cutaneous T-Cell Lymphoma, Mycosis Fungoides) Stage 1A, 1B, 2A Completed NCT00221039 Phase 4 Methoxsalen+ECP
38 Pilot Study of Combination Therapy With CHOP-Zenapax (CHOP-daclizumab) Completed NCT01418430 Phase 4 CHOP-daclizumab
39 PROMPT - Palifermin in Reduction of Oral Mucositis in PBSC Transplantation Completed NCT00352703 Phase 4 Kepivance (Palifermin)
40 Epoetin Alfa (Hemax®) Phase IV Study in Chemotherapy Induced Anemia Completed NCT01374373 Phase 4
41 Effect of Epoetin Alfa on Hemoglobin, Symptom Distress, and Quality of Life in Patients Receiving Chemotherapy Completed NCT00524407 Phase 4 Epoetin alfa
42 Evaluation of the Analgesy With Emla and/or Nitrous Oxide in Pediatric Patients for Lumbar Puncture Completed NCT00808171 Phase 4 Livopan;Livopan;EMLA
43 ALL-REZ BFM 2002: Multi-Center Study for Children With Relapsed Acute Lymphoblastic Leukemia Completed NCT00114348 Phase 4
44 DepoCyt Therapy in Patients With Neoplastic Meningitis From Lymphoma or a Solid Tumor Completed NCT00029523 Phase 4 Intrathecal (injected into the spinal fluid) DepoCyt;Intrathecal methotrexate;Intrathecal cytarabine (also known as ara-C)
45 AMENO-2: Aprepitant Plus Palonosetron Versus Granisetron in the Prevention of Nausea and the Emesis Induced by Chemotherapy in Patients Treated With Haematopoietic Progenitors Completed NCT00415103 Phase 4 Aprepitant;Palonosetron;Granisetron
46 A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer Completed NCT00277160 Phase 4 Neulasta (pegfilgrastim)
47 10-day Versus 14-day Concomitant PAMC as First-line Treatment Strategy for the Eradication of H. Pylori Infection Completed NCT02959255 Phase 4 Esomeprazole
48 Subcutaneous Amifostine Safety Study Completed NCT00158041 Phase 4 Amifostine administered subcutaneously
49 Intraluminal Therapy for Helicobacter Pylori Infection Completed NCT03124420 Phase 4 Lansoprazole;Amoxicillin;Clarithromycin
50 Bone Marrow Transplantation in Treating Patients With Hematologic Cancer Completed NCT00003398 Phase 4 cyclophosphamide;thiotepa

Search NIH Clinical Center for Lymphosarcoma

Inferred drug relations via UMLS 73 / NDF-RT 51 :


Genetic Tests for Lymphosarcoma

Anatomical Context for Lymphosarcoma

MalaCards organs/tissues related to Lymphosarcoma:

41
B Cells, T Cells, Bone, Bone Marrow, Lung, Myeloid, Nk Cells

Publications for Lymphosarcoma

Articles related to Lymphosarcoma:

(show top 50) (show all 1246)
# Title Authors Year
1
Secondary Syphilis with Tonsillar and Cervical Lymphadenopathy and a Pulmonary Lesion Mimicking Malignant Lymphoma. ( 29502129 )
2018
2
Myeloid Sarcoma Presented as Generalized Lymphadenopathy: Mimicking Malignant Lymphoma. ( 29398826 )
2018
3
Cytomegalovirus retinitis in a patient with secondary acute lymphosarcoma leukemia undergoing allogeneic hematopoietic stem-cell transplantation: A rare case report: a care-compliant article. ( 28489788 )
2017
4
Association between increased serum GP88 (progranulin) concentrations and prognosis in patients with malignant lymphomas. ( 28823651 )
2017
5
miRNases: Novel peptide-oligonucleotide bioconjugates that silence miR-21 in lymphosarcoma cells. ( 28126663 )
2017
6
CD3 and CD20 Immunohistochemical Staining Patterns of Bone Marrow-Infiltrating Malignant Lymphoma Cells. ( 28442514 )
2017
7
Lymphedema of the Lower Extremities due to Refractory Malignant Lymphoma Treated by Lymphaticovenous Anastomosis. ( 28894674 )
2017
8
Primary Malignant Lymphoma Originating from the Chest Wall without Preceding Pleural Disease. ( 28321070 )
2017
9
Acute Lameness in a Roller Pigeon ( Columba livia ) with Multicentric Lymphosarcoma. ( 28665728 )
2017
10
Immunohistochemical analysis of the novel marginal zone B-cell marker IRTA1 in malignant lymphoma. ( 27666766 )
2017
11
Association of BoLA-DRB3.2 Alleles with BLV Infection Profiles (Persistent Lymphocytosis/Lymphosarcoma) and Lymphocyte Subsets in Iranian Holstein Cattle. ( 26782666 )
2016
12
[Malignant lymphoma presented as recurrent multiple cranial nerve palsy after spontaneous regression of oculomotor nerve palsy: A case report]. ( 26616489 )
2016
13
Gene mutations in malignant lymphoma. ( 28090025 )
2016
14
Management of Primary Malignant Lymphoma of the Parotid Gland in a series of 745 patients. ( 26871900 )
2016
15
Aberrant expression of napsin A in a subset of malignant lymphomas. ( 26400099 )
2016
16
Primary malignant lymphoma of the uterus: a report of four cases. ( 27172736 )
2016
17
Massive Localized Lymphedema in the Morbidly Obese Patient: A Clinical Entity Mimicking Lymphosarcoma. ( 26367787 )
2015
18
Cardiac Sarcoidosis Masked by Malignant Lymphoma. ( 27094123 )
2015
19
Pattern of MEF2B expression in lymphoid tissues and in malignant lymphomas. ( 26089142 )
2015
20
Primary malignant lymphoma of the trigeminal nerve: case report and literature review. ( 25797078 )
2015
21
Comparison of field-in-field radiotherapy with conformal radiotherapy for unilateral cervical malignant lymphoma. ( 26289909 )
2015
22
microRNA in Malignant Lymphoma. ( 26658995 )
2015
23
Genomic alterations underlying immune privilege in malignant lymphomas. ( 26049756 )
2015
24
Primary malignant lymphoma combined with clinically "silent" pheochromocytoma in the same adrenal gland. ( 26419235 )
2015
25
Primary malignant lymphoma of the uterus and broad ligament: a case report and review of literature. ( 25674001 )
2015
26
South African report of first case of chromoblastomycosis caused by Cladosporium (syn Cladophialophora) carrionii infection in a cat with feline immunodeficiency virus and lymphosarcoma. ( 25425600 )
2015
27
Common consensus LNA probe for quantitative PCR assays in cancer: vehicles for minimal residual disease detection in t(11;14) and t(14;18) positive malignant lymphomas. ( 24631717 )
2014
28
Refractory seborrheic dermatitis of the head in a patient with malignant lymphoma. ( 25566053 )
2014
29
Role of polymorphic loci in HLA-region rs2647012 and rs805288 in the development of non-Hodgkin's malignant lymphomas in Western Siberia. ( 24958370 )
2014
30
Monoclonal hyperglobulinemia in lymphosarcoma in a cockatiel (Nymphicus hollandicus) and a blue and gold macaw (Ara ararauna). ( 25055643 )
2014
31
Takayasu's arteritis misdiagnosed as mediastinal malignant lymphoma: a case report and review of the literature. ( 24977018 )
2014
32
Cloacolithiasis and intestinal lymphosarcoma in an African black-footed penguin (Spheniscus demersus). ( 25000718 )
2014
33
Focal thoracolumbar spinal cord lymphosarcoma in a ferret (Mustela putorius furo). ( 24982519 )
2014
34
Analysis of the association of polymorphic loci rs917997 in IL18RAP gene and rs187238 in IL18 gene with the risk for non-Hodgkin's malignant lymphomas in Novosibirsk population. ( 24909718 )
2014
35
Hematopathology: LC14-1 SMALL B-CELL LYMPHOMAS. DIAGNOSIS OF MALIGNANT LYMPHOMAS IN 2014. ( 25188095 )
2014
36
Percutaneous image-guided biopsy for non-mass-forming isolated splenomegaly and suspected malignant lymphoma. ( 25365519 )
2014
37
Dynamics of oxidative modification of proteins and specific structural features of blood plasma from animals with Pliss lymphosarcoma. ( 23658922 )
2013
38
c-Myc and E2F1 drive PBK/TOPK expression in high-grade malignant lymphomas. ( 23237560 )
2013
39
Isolated primary malignant lymphoma arising from the optic chiasm. ( 23932421 )
2013
40
Malignant lymphoma in primary SjAPgren's syndrome: an update on the pathogenesis and treatment. ( 23816048 )
2013
41
ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL). ( 23175624 )
2013
42
Expression of FoxO3a in clinical cases of malignant lymphoma. ( 24021689 )
2013
43
Role of microRNA in the pathogenesis of malignant lymphoma. ( 23551855 )
2013
44
Reactivation of hepatitis B virus in patients with undetectable HBsAg undergoing chemotherapy for malignant lymphoma or multiple myeloma. ( 23926082 )
2013
45
The effect of novel rhenium compounds on lymphosarcoma, PC-3 prostate and myeloid leukemia cancer cell lines and an investigation on the DNA binding properties of one of these compounds through electronic spectroscopy. ( 25221731 )
2013
46
Secondary syphilis presenting as a generalized lymphadenopathy: clinical mimicry of malignant lymphoma. ( 23680905 )
2013
47
Feline small cell lymphosarcoma versus inflammatory bowel disease: diagnostic challenges. ( 23677821 )
2013
48
Posterior mediastinal malignant lymphoma mimicking a neurogenic tumor. ( 23336918 )
2013
49
Primary malignant lymphoma in the deep palmar tissue. ( 22496181 )
2013
50
Feline small cell lymphosarcoma versus inflammatory bowel disease: treatment and prognosis. ( 23814916 )
2013

Variations for Lymphosarcoma

Expression for Lymphosarcoma

Search GEO for disease gene expression data for Lymphosarcoma.

Pathways for Lymphosarcoma

GO Terms for Lymphosarcoma

Biological processes related to Lymphosarcoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 gene silencing by miRNA GO:0035195 9.5 MIR19A MIR20A MIR92A1
2 positive regulation of B cell proliferation GO:0030890 9.37 BCL6 PTPRC
3 negative regulation of cardiac muscle cell apoptotic process GO:0010667 9.26 MIR19A MIR20A
4 pentose-phosphate shunt GO:0006098 9.16 G6PD H6PD
5 NADP metabolic process GO:0006739 8.96 G6PD H6PD
6 negative regulation of sprouting angiogenesis GO:1903671 8.8 MIR19A MIR20A MIR92A1

Molecular functions related to Lymphosarcoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 carbohydrate binding GO:0030246 9.43 CD22 G6PD H6PD
2 mRNA binding involved in posttranscriptional gene silencing GO:1903231 9.33 MIR19A MIR20A MIR92A1
3 NADP binding GO:0050661 9.13 G6PD GSR H6PD
4 glucose-6-phosphate dehydrogenase activity GO:0004345 8.62 G6PD H6PD

Sources for Lymphosarcoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....